Pfizer to complete supply of COVID-19 vaccines to EU by September

The distribution of an initial 200 million doses of the COVID-19 vaccine developed by Pfizer and BioNTech across the European Union will be completed by September, a spokesman for the EU Commission said on Monday.

On Monday, reports indicated that the delivery of the Pfizer-BioNTech COVID-19 vaccine has been delayed to eight European countries, including Malta, after a logistical problem arose regarding the temperature the doses need to be kept at. 

Logistics issues delay vaccine delivery
Pfizer vaccine deliveries delayed – reports

The protracted timetable, previously unknown, confirms that the 450-million bloc will need vaccines from other suppliers to speed up inoculations against the new coronavirus.

Most EU countries began inoculating healthcare workers andvulnerable people on Sunday with the Pfizer vaccine, the only one so far authorised in the 27-nation bloc. It requires a two-dose regimen. 

The spokesperson said talks were underway to agree the delivery of a further 100 million doses which are optional under the contract sealed with the two companies.